![Marcela Maus](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marcela Maus
Directeur/Membre du Conseil chez
Ichnos Sciences, Inc.
Profil
Marcela V.
Maus is the founder of Century Therapeutics, Inc. (2018).
Current jobs include Director-Cellular Immunotherapy at The Massachusetts General Hospital, Non-Executive Director at Ichnos Glenmark Innovation, Inc., Associate Member at Harvard University, Associate Member at Massachusetts Institute of Technology, Associate Professor at Harvard Medical School, and Associate Member at The Ragon Institute of MGH MIT & Harvard.
Former jobs include Director at bluebird bio, Inc. (2021) and Independent Director at 2seventy Bio, Inc. (2021-2025).
Education includes a doctorate from the University of Pennsylvania and an undergraduate degree from Massachusetts Institute of Technology.
Postes actifs de Marcela Maus
| Sociétés | Poste | Début |
|---|---|---|
Ichnos Sciences, Inc.
 Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Directeur/Membre du Conseil | - |
The Ragon Institute of MGH MIT & Harvard
 The Ragon Institute of MGH MIT & Harvard Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit that engages in biomedical research institute focuses on harnessing the human immune system to prevent and cure disease | Corporate Officer/Principal | - |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The Massachusetts General Hospital
 The Massachusetts General Hospital Hospital/Nursing ManagementHealth Services Operates as a cancer care hospital | Corporate Officer/Principal | - |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Corporate Officer/Principal | - |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Marcela Maus
| Sociétés | Poste | Fin |
|---|---|---|
| 2SEVENTY BIO, INC. | Directeur/Membre du Conseil | 13/05/2025 |
| GENETIX BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 04/11/2021 |
| CENTURY THERAPEUTICS, INC. | Fondateur | - |
Formation de Marcela Maus
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The Massachusetts General Hospital
The Massachusetts General Hospital Hospital/Nursing ManagementHealth Services Operates as a cancer care hospital | Health Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ragon Institute of MGH MIT & Harvard
The Ragon Institute of MGH MIT & Harvard Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit that engages in biomedical research institute focuses on harnessing the human immune system to prevent and cure disease | Commercial Services |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Health Technology |
2seventy Bio, Inc.
 2seventy Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for the treatment of cancer and genetic diseases | Health Technology |
